Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer.

@article{LeBeau2013TargetingUW,
  title={Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer.},
  author={Aaron M LeBeau and Sai Duriseti and Stephanie T. Murphy and François Pepin and Byron Hann and Joe W. Gray and Henry F. Vanbrocklin and Charles S. Craik},
  journal={Cancer research},
  year={2013},
  volume={73 7},
  pages={2070-81}
}
Components of the plasminogen activation system, which are overexpressed in aggressive breast cancer subtypes, offer appealing targets for development of new diagnostics and therapeutics. By comparing gene expression data in patient populations and cultured cell lines, we identified elevated levels of the urokinase plasminogen activation receptor (uPAR, PLAUR) in highly aggressive breast cancer subtypes and cell lines. Recombinant human anti-uPAR antagonistic antibodies exhibited potent binding… CONTINUE READING
21 Citations
41 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Prognostic factors in 1,038womenwithmetastatic breast cancer

  • R Largillier, JM Ferrero, J Doyen, J Barriere, M Namer, V Mari
  • Ann Oncol 2008;19:2012–9
  • 2012
1 Excerpt

The role of chemotherapy and targeted agents in patients with metastatic breast cancer

  • Johnston
  • Eur J Cancer 2011;47 Suppl 3:S38–47
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…